Skip to main content Accessibility help
×
Home

Human Genetics Society of Australasia Position Statement: Population-Based Carrier Screening for Cystic Fibrosis

  • Martin B. Delatycki (a1) (a2), Jo Burke (a3), Louise Christie (a4), Felicity Collins (a5), Michael Gabbett (a6), Peter George (a7), Eric Haan (a8), Liane Ioannou (a2) (a9), Nicole Martin (a10), Fiona McKenzie (a11), Peter O’Leary (a12), Nicole Scoble-Williams (a13), Gillian Turner (a14) and John Massie (a2) (a15)...

Abstract

Since the discovery in 1989 that mutations in cystic fibrosis transmembrane conductance regulator (CFTR) underlie cystic fibrosis (CF), the most common life shortening genetic disorder in Caucasians, it has been possible to identify heterozygous mutation carriers at risk of having affected children. The Human Genetics Society of Australasia has produced a position statement with recommendations in relation to population-based screening for CF. These include: (1) that screening should be offered to all relatives of people with or carriers of CF (cascade testing) as well as to all couples planning to have children or who are pregnant; (2) the minimum CFTR mutation panel to be tested consists of 17 mutations which are those mutations that are associated with typical CF and occur with a frequency of 0.1% or higher among individuals diagnosed with CF in Australasia; (3) that genetic counselling is offered to all couples where both members are known to have one or two CFTR mutations and that such couples are given the opportunity to meet with a physician with expertise in the management of CF as well as a family/individual affected by the condition.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Human Genetics Society of Australasia Position Statement: Population-Based Carrier Screening for Cystic Fibrosis
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Human Genetics Society of Australasia Position Statement: Population-Based Carrier Screening for Cystic Fibrosis
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Human Genetics Society of Australasia Position Statement: Population-Based Carrier Screening for Cystic Fibrosis
      Available formats
      ×

Copyright

Corresponding author

address for correspondence: Professor Martin Delatycki, Clinical Genetics, Austin Health, Studley Road, Heidelberg VIC 3084, Australia. E-mail: martin.delatycki@austin.org.au

References

Hide All
American College of Obstetricians and Gynecologists Committee on Genetics. (2011). ACOG committee opinion no. 486: Update on carrier screening for cystic fibrosis. Obstetrics and Gynecology, 117, 10281031.
Diso, D., Anile, M., Patella, M., Pecoraro, Y., Rendina, E. A., Carillo, C., . . . Venuta, F. (2013). Lung transplantation for cystic fibrosis: Outcome of 101 single-center consecutive patients. Transplantation Proceedings, 45, 346348.
Grody, W. W., Thompson, B. H., Gregg, A. R., Bean, L. H., Monaghan, K. G., Schneider, A., . . . Lebo, R. V. (2013). ACMG position statement on prenatal/preconception expanded carrier screening. Genetics in Medicine, 15, 482483.
Haddow, J., & Palomaki, G. (2002). Population based prenatal screening for cystic fibrosis by carrier testing. ACCE: Centers for Disease Control and Prevention (USA).
Ioannou, L., Massie, J., Collins, V., McClaren, B., & Delatycki, M. B. (2010). Population-based genetic screening for cystic fibrosis: Attitudes and outcomes. Public Health Genomics, 13, 449456.
Ioannou, L., McClaren, B., Massie, J., Lewis, S., Metcalfe, S., Forrest, L., . . . Delatycki, M. B. (2014). Population-based carrier screening for cystic fibrosis: A systematic review of 23 years of research. Genetics in Medicine, 16, 207216.
Khoury, M. J., McCabe, L. L., & McCabe, E. R. (2003). Population screening in the age of genomic medicine. New England Journal of Medicine, 348, 5058.
Massie, J., Petrou, V., Forbes, R., Curnow, L., Ioannou, L., Dusart, D., . . . Delatycki, M. B. (2009). Population-based carrier screening for cystic fibrosis in Victoria: The first three years experience. Australian and New Zealand Journal of Obstetrics and Gynaecology, 49, 484489.
Radhakrishnan, M., van Gool, K., Hall, J., Delatycki, M., & Massie, J., (2008). Economic evaluation of cystic fibrosis screening: A review of the literature. Health Policy, 85, 133147.
Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Drevinek, P., . . . Elborn, J. S. (2011). A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. New England Journal of Medicine, 365, 16631672.
Rowley, P. T., Loader, S., Kaplan, R. M., (1998). Prenatal screening for cystic fibrosis carriers: An economic evaluation. American Journal of Human Genetics, 63, 11601174.
Thauvin-Robinet, C., Munck, A., Huet, F., Genin, E., Bellis, G., Gautier, E., . . . Girodon, E. (2009). The very low penetrance of cystic fibrosis for the R117H mutation: A reappraisal for genetic counselling and newborn screening. Journal of Medical Genetics, 46, 752758.
Wilson, J., & Junger, G. (1968). The principles and practice of screening for disease (Public Health Paper 34). Geneva: World Health Organization.

Keywords

Human Genetics Society of Australasia Position Statement: Population-Based Carrier Screening for Cystic Fibrosis

  • Martin B. Delatycki (a1) (a2), Jo Burke (a3), Louise Christie (a4), Felicity Collins (a5), Michael Gabbett (a6), Peter George (a7), Eric Haan (a8), Liane Ioannou (a2) (a9), Nicole Martin (a10), Fiona McKenzie (a11), Peter O’Leary (a12), Nicole Scoble-Williams (a13), Gillian Turner (a14) and John Massie (a2) (a15)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed